Who Owns CTMX?

CytomX Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$4.11

-0.18 (-4.31%)

Market Cap

$757.6M

Shares Outstanding

170,250,931

Institutional Holders

66

Total Inst. Value

$27.2M

% of Float Held

34.2%

QoQ Holder Change

-7

Institutional data as of Q1 2025

New Positions

9

Closed Positions

11

Increased

20

Decreased

25

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1TANG CAPITAL MANAGEMENT LLC$4.3M6,717,825
2BVF INC/IL$3.3M5,228,461
3VANGUARD GROUP INC$3.3M5,117,376
4Prosight Management, LP$2.5M3,930,008
5ACADIAN ASSET MANAGEMENT LLC$2.1M3,234,035
6Point72 Asset Management, L.P.$1.7M2,650,000
7Woodline Partners LPNew$1.1M1,657,306
8Laurion Capital Management LP$823K1,293,686
9BlackRock, Inc.$742K1,166,384
10RENAISSANCE TECHNOLOGIES LLC$735K1,156,000

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold CTMX?

As of Q1 2025, 66 institutional investors report holding CTMX (CytomX Therapeutics, Inc.) in their 13F filings.

What percentage of CytomX Therapeutics, Inc. is owned by institutions?

Institutional investors hold approximately 34.2% of CytomX Therapeutics, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most CTMX?

The largest institutional holder of CTMX is TANG CAPITAL MANAGEMENT LLC with $4.3M in shares.

Are institutions buying or selling CTMX?

This quarter, 9 institutions opened new positions in CTMX and 11 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.